Brief: Epigenomics H1 EBITDA Loss At EUR -3.2 Mln
11/08/2021 07:04
Aug 11 (Reuters) - EPIGENOMICS AG ECXn.DE :
* REPORTS FINANCIAL RESULTS FOR THE FIRST SIX MONTHS OF 2021
* H1 EBITDA LOSS -3.165 MILLION EUR VERSUS -5.659 MILLION
EUR LOSS
YEAR AGO
* IN FIRST SIX MONTHS OF 2021, TOTAL REVENUE DECREASED FROM
EUR
322 THOUSAND IN FIRST HALF OF 2020 TO EUR 223 THOUSAND
* H1 NET LOSS FOR PERIOD WAS EUR -3,528 THOUSAND (6M 2020:
EUR
-6,403 THOUSAND);
Source text for Eikon: ID:nEQcggPSDa
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns